• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Experimental haemorrhage and blood component transfusion in humans: no change in plasma concentration of thrombin-antithrombin complex and plasmin-antiplasmin complex.

作者信息

Henriksson A E, Nilsson T K, Jansson U, Bergqvist D

机构信息

Department of Surgery, County Hospital, Sundsvall, Sweden.

出版信息

Thromb Res. 1996 Jun 1;82(5):409-15. doi: 10.1016/0049-3848(96)00090-4.

DOI:10.1016/0049-3848(96)00090-4
PMID:8771701
Abstract

The influence of haemorrhage and blood transfusion on primary haemostasis, coagulation and fibrinolysis was investigated in ten healthy male volunteers. Acute loss of 10% of the blood volume did not give any significant alteration in thrombin- antithrombin III (TAT) complex and plasmin-alpha 2-antiplasmin (PAP) complex levels compared with a control series. The skin bleeding time with the Simplate II device was not altered after the 10% blood loss. Acute loss of 10% of blood volume followed by transfusion of packed red cells or stored plasma did not resulted in any significant change in bleeding time, TAT and PAP complex levels. It could be concluded that a controlled haemorrhage does not give any detectable changes of the platelet dependent primary haemostasis, blood coagulation and fibrinolysis. Transfusion of one unit of packed red cells or stored plasma does not seem to adversely affect the haemostasis.

摘要

相似文献

1
Experimental haemorrhage and blood component transfusion in humans: no change in plasma concentration of thrombin-antithrombin complex and plasmin-antiplasmin complex.
Thromb Res. 1996 Jun 1;82(5):409-15. doi: 10.1016/0049-3848(96)00090-4.
2
Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.糖尿病中血液凝固和纤维蛋白溶解的激活:通过血浆凝血酶 - 抗凝血酶III复合物和纤溶酶 - α2 - 纤溶酶抑制剂复合物水平进行评估
Thromb Res. 1989 Sep 15;55(6):727-35. doi: 10.1016/0049-3848(89)90303-4.
3
Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.体外膜肺氧合中凝血和纤维蛋白溶解激活标志物的年龄差异。
Pediatr Crit Care Med. 2014 Jun;15(5):e198-205. doi: 10.1097/PCC.0000000000000107.
4
Significance of elevated thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage.凝血酶 - 抗凝血酶III复合物及纤溶酶 - α2 - 纤溶酶抑制物复合物升高在非创伤性蛛网膜下腔出血急性期的意义
Neurosurgery. 1994 Dec;35(6):1055-60. doi: 10.1227/00006123-199412000-00006.
5
Coagulation and fibrinolysis activation markers in prostatic carcinoma patients.前列腺癌患者的凝血和纤维蛋白溶解激活标志物
Eur J Clin Chem Clin Biochem. 1997 Feb;35(2):69-72. doi: 10.1515/cclm.1997.35.2.69.
6
Thrombin generation in patients with thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜患者的凝血酶生成
Am J Hematol. 1989 Dec;32(4):255-7. doi: 10.1002/ajh.2830320404.
7
[Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].糖尿病肾病凝血-纤溶系统的研究——参考血浆凝血酶-抗凝血酶复合物及α2纤溶酶抑制物
Nihon Jinzo Gakkai Shi. 1990 Sep;32(9):995-9.
8
Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer.
Tumori. 1998 May-Jun;84(3):364-7. doi: 10.1177/030089169808400310.
9
Time course of clotting and fibrinolytic markers in acute upper gastrointestinal bleeding: relation to diagnosis and blood transfusion treatment.急性上消化道出血时凝血和纤溶标志物的时间进程:与诊断及输血治疗的关系
Blood Coagul Fibrinolysis. 1993 Dec;4(6):877-80.
10
Thrombin-antithrombin complex and alpha2-plasmin inhibitor-plasmin complex levels after cesarean section in normal pregnancies and pre-eclampsia.正常妊娠和子痫前期剖宫产术后凝血酶 - 抗凝血酶复合物及α2 - 纤溶酶抑制物 - 纤溶酶复合物水平
Int J Gynaecol Obstet. 2003 Aug;82(2):213-6. doi: 10.1016/s0020-7292(03)00193-0.